DHER34:BVMF
Danaher Corporation
R$Â 39,00
arrow_downward
-0,81%(-0,32) 1D
8 okt, 16:56:00 GMT-3 · BRL
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor DHER34 genereren…
Openen
R$Â 38,61
Hoog
R$Â 39,04
Laag
R$Â 38,00
Beursw.
152,87Â mld.
Gem. vol.
2,40K
Volume
39,00
52 wk hoog
R$Â 45,87
52 wk laag
R$Â 27,94
Uitstaande aandelen
702,99Â mln.
Aantal medewerkers
59K
Openen
R$Â 38,61
Hoog
R$Â 39,04
Laag
R$Â 38,00
Beursw.
152,87Â mld.
Gem. vol.
2,40K
Volume
39,00
52 wk hoog
R$Â 45,87
52 wk laag
R$Â 27,94
Uitstaande aandelen
702,99Â mln.
Aantal medewerkers
59K
Nieuwsartikelen
Van webbronnen en nieuwspartners
Yahoo Finance
·
1 uur geleden
Is Danaher (DHR) Undervalued As Its New AI Lab Pushes Faster Antibody Development?
Global Venturing
·
8 uur geleden
Venkatesan leaves head of investment role at Danaher
Reuters
·
1 dag geleden
Life sciences firm Danaher to launch AI-powered autonomous research lab in 2027
Investing.com
·
1 dag geleden
Danaher plans AI-powered autonomous lab for antibody research
Profiel
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
Over Danaher Corporation